Prof. Richard Hindley

Prof. Richard Hindley
Richard is the lead surgeon in the UK for pioneering minimally invasive treatments such as Aquablation. In 2018, Richard received the honour of Visiting Professor of Knowledge Exchange for Winchester University in the Health and Wellbeing Research Group and was also recently appointed as a Specialist Adviser to NICE’s Interventional Procedures Programme. Having qualified in Scotland at the University of Dundee, Richard spent his initial surgical training in Brighton before embarking on 6 years specialist Urology training based in the South Thames training region. This included 2 years at King’s Hospital before passing his final surgical exams and travelling to Brisbane for a laparoscopic urology fellowship in 2003. He was later appointed as a consultant in Basingstoke in 2004. Since then he has spent the last 10 years developing the local service and his interests in minimally invasive treatments for urological conditions. Richard is the clinical lead in Urology in his department at the North Hampshire Hospital. He has introduced cutting edge treatments including the first centre outside of London offering day case laser prostate surgery for BPH in 2005. He is also a recognised expert in prostate cancer diagnosis and focal treatment using technologies such as HIFU and Cryotherapy. Basingstoke is now one of the leading centres in the UK and receives referrals from across the South of England. He has very much been at the forefront of treatments for benign and malignant conditions of the prostate. He is also a very experienced laparoscopic renal surgeon and is now using the Da Vinci robot for the treatment of kidney conditions. Richard enjoys teaching and training and has helped to introduce laparoscopy, HIFU and Greenlight laser surgery to centres around the UK. He has a large research portfolio and is currently recruiting over 50 patients per year to prostate related clinical trials. He has recently been appointed as Chair of the GIRFT Academy for bladder outlet obstruction, which has been set up to improve the quality of care for men with symptomatic BPH and reduce regional variations in practice.

Locations

NHS Basingstoke and North Hampshire Hospital Basingstoke,

Aldermaston RdBasingstoke, RG24 9NAUnited Kingdom
01256 377 664 | Visit Website

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only